Sep 20, 2023
Sleep Aids Market: Examining Cutting-Edge Technologies and Scientific Breakthroughs Sleep can be burdensome when it disrupts daily routines, requires a significant time commitment, and is marred by sleep disorders or disturbances that affect overall well-being. In today's fast-paced world, where stress, anxiety,...
Read More...
Sep 18, 2023
Huntington’s disease is an incurable, rare genetic, progressive neurodegenerative disorder. According to the National Organization for Rare Disorders (NORD), about 30,000 people in the United States have Huntington’s disease, and another 200,000 are at risk of developing the condition. As per DelveInsight analy...
Read More...
Sep 15, 2023
The dynamics of the myelodysplastic syndrome treatment market are anticipated to change in the coming years owing to the emerging therapies.
Read More...
Sep 04, 2023
As per Delveinsight, the Fabry disease treatment market is likely boost enormous contribution from conventional enzyme replacement therapies.
Read More...
Aug 25, 2023
There have been tremendous advancements in homozygous familial hypercholesterolemia treatment, yet several unmet needs are to be fulfilled.
Read More...
Aug 21, 2023
On August 04, 2023, the FDA has approved Biogen and Sage Therapeutics' Zuranolone as the first tablet for postpartum depression treatment.
Read More...
Aug 18, 2023
On 4 August 2023, FDA has approved Iveric Bio’s Izervay as the treatment of geographic atrophy secondary to age-related macular degeneration.
Read More...
Aug 16, 2023
Anti-snoring Devices demand is growing with rising awareness. Companies are actively working in the market to develop new products.
Read More...
Aug 14, 2023
Although there has been tremendous investment in chronic spontaneous urticaria treatment, there are still gray areas that require attention.
Read More...
Aug 02, 2023
Herbal Medicines are made from plant extracts and are helpful in treating diseases. Companies in the Herbal product market engaged in R&D
Read More...
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Newsletter/Whitepaper